Immuron Ltd ADR (IMRN)

$1.10 +0.01 (0.46%)
Market Cap 8.84M
Revenue (ttm) 4.72M
Net Income (ttm) -3.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -71.61%
Debt to Equity Ratio 0.00
Volume 32,600
Avg Vol 295,128
Day's Range N/A - N/A
Shares Out 8.07M
Stochastic %K 29%
Beta 1.16
Analysts Strong Buy
Price Target $5.00

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3 Carlton South, Carlton, Australia
ScanStock
ScanStock Jul. 28 at 10:17 PM
Big bulls calling you APUS right now for a run! Looks like they might be right, Loads of bulls moving to APUS now! The next low float stock to squeeze north Look APUS starting to run with fresh news <-- $BDRX $BJDX $IMRN $VKTX long it
0 · Reply
Baseball89
Baseball89 Jul. 27 at 11:21 PM
$IMRN
0 · Reply
prismmarketview
prismmarketview Jul. 16 at 8:45 PM
$IMRN Immuron Ltd. reported unaudited global Travelan sales reached AUD$7.7 million for the full fiscal year 2026, marking a 6% increase over the prior year and delivering four consecutive quarters of year-over-year revenue growth. https://prismmarketview.com/companies/immuron-limited/#news
0 · Reply
STACKD0E
STACKD0E Jul. 16 at 10:57 AM
$BRIA $IMRN $EVTL $AIRO $TMQ ✨️
0 · Reply
jamsolotradez
jamsolotradez Jul. 10 at 1:42 PM
$IMRN wheres the volume at?
0 · Reply
jamsolotradez
jamsolotradez Jul. 10 at 1:41 PM
$IMRN let this week be the week 🤣
0 · Reply
jamsolotradez
jamsolotradez Jul. 10 at 1:41 PM
$IMRN
0 · Reply
Tryitin
Tryitin Jul. 9 at 10:33 PM
$IMRN Holding gains for the third day and chart is prepping for a spike up IMO. Just a matter of time but imminent!
0 · Reply
Victorious123
Victorious123 Jul. 9 at 7:34 PM
$IMRN
0 · Reply
jamsolotradez
jamsolotradez Jul. 9 at 8:45 AM
$IMRN on my way back from the school run and were still grinding up, lets see what today holds $2+ is easy if we brake through $1.60
0 · Reply
Latest News on IMRN
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year

Thu, 16 Jul 2026 06:00:00 -0400 - 14 days ago

Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

Mon, 06 Jul 2026 06:00:00 -0400 - 24 days ago

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00

Wed, 22 Apr 2026 09:00:00 -0400 - 3 months ago

Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00

Immuron Double Digit 3Q Sales Growth

Fri, 17 Apr 2026 06:00:00 -0400 - 3 months ago

Immuron Double Digit 3Q Sales Growth

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target

Thu, 05 Mar 2026 11:05:00 -0500 - 5 months ago

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target

Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference

2026-03-05T11:00:00.000Z - 5 months ago

Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target

Thu, 22 Jan 2026 06:00:00 -0500 - 6 months ago

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target

Immuron Reports Continued Sales Growth

Mon, 19 Jan 2026 06:00:00 -0500 - 6 months ago

Immuron Reports Continued Sales Growth

Why Is Immuron Stock (IMRN) Down Today?

2025-12-10T13:49:49.000Z - 8 months ago

Why Is Immuron Stock (IMRN) Down Today?

Immuron (IMRN) Collaborates on Vaccine Research with US Military Institutes

2025-12-03T11:53:11.000Z - 8 months ago

Immuron (IMRN) Collaborates on Vaccine Research with US Military Institutes

Immuron anounces new DoD award and clinical trial updates

2025-12-03T11:10:43.000Z - 8 months ago

Immuron anounces new DoD award and clinical trial updates

Immuron (IMRN) Secures FDA Approval for Phase 2 Trial of IMM-529

2025-11-05T11:58:49.000Z - 9 months ago

Immuron (IMRN) Secures FDA Approval for Phase 2 Trial of IMM-529

Immuron announces FDA approval of IND for IMM-529

2025-11-05T11:25:57.000Z - 9 months ago

Immuron announces FDA approval of IND for IMM-529

Immuron: FDA Approves IND Application For IMM-529

2025-11-05T11:25:02.000Z - 9 months ago

Immuron: FDA Approves IND Application For IMM-529

Immuron IMM-529 IND approved by FDA

Wed, 05 Nov 2025 06:00:00 -0500 - 9 months ago

Immuron IMM-529 IND approved by FDA

Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target

Fri, 17 Oct 2025 11:07:00 -0400 - 10 months ago

Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target

Immuron Announces Rise In Global Revenue For Q1

2025-10-13T12:54:51.000Z - 10 months ago

Immuron Announces Rise In Global Revenue For Q1

Immuron Q1 FY26 YoY growth

Mon, 13 Oct 2025 06:00:00 -0400 - 10 months ago

Immuron Q1 FY26 YoY growth

Immuron (IMRN) Seeks FDA Green Light for Novel C. diff Treatment

2025-10-08T11:31:48.000Z - 10 months ago

Immuron (IMRN) Seeks FDA Green Light for Novel C. diff Treatment

Why Immuron Is Rising In Pre-market?

2025-10-08T10:16:00.000Z - 10 months ago

Why Immuron Is Rising In Pre-market?

Immuron submitts IND application to FDA for clinical development of IMM-529

2025-10-08T10:05:07.000Z - 10 months ago

Immuron submitts IND application to FDA for clinical development of IMM-529

Immuron Submits IMM-529 IND to FDA

Wed, 08 Oct 2025 06:00:00 -0400 - 10 months ago

Immuron Submits IMM-529 IND to FDA

Immuron (IMRN) Updates Shareholders on Key Project Developments

2025-10-02T11:26:44.000Z - 10 months ago

Immuron (IMRN) Updates Shareholders on Key Project Developments

Immuron announces projects update

2025-10-02T10:20:08.000Z - 10 months ago

Immuron announces projects update

Immuron Letter to Shareholders – Projects Update

Thu, 02 Oct 2025 06:00:00 -0400 - 10 months ago

Immuron Letter to Shareholders – Projects Update

Immuron enters partnership with InvestorHub

2025-08-27T09:20:17.000Z - 1 year ago

Immuron enters partnership with InvestorHub

Immuron partners with InvestorHub

Tue, 26 Aug 2025 22:29:00 -0400 - 1 year ago

Immuron partners with InvestorHub

Immuron says FY25 global sales exceed projection, up 49% over prior year

2025-07-17T10:05:32.000Z - 1 year ago

Immuron says FY25 global sales exceed projection, up 49% over prior year

Immuron - FY25 global sales exceed projection, up 49% on prior year

Thu, 17 Jul 2025 06:00:00 -0400 - 1 year ago

Immuron - FY25 global sales exceed projection, up 49% on prior year

Immuron Letter to Shareholders: Projects Update

Fri, 30 May 2025 06:00:00 -0400 - 1 year ago

Immuron Letter to Shareholders: Projects Update

Immuron (IMRN) Achieves Record Sales Milestone

2025-04-11T08:55:40.000Z - 1 year ago

Immuron (IMRN) Achieves Record Sales Milestone

Immuron Travelan® highest sales in history

Thu, 10 Apr 2025 18:00:00 -0400 - 1 year ago

Immuron Travelan® highest sales in history

Immuron partners with Calmino to distribute ProIBS in Australia, New Zealand

2025-03-05T11:06:32.000Z - 1 year ago

Immuron partners with Calmino to distribute ProIBS in Australia, New Zealand

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Wed, 05 Mar 2025 06:00:00 -0500 - 1 year ago

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Immuron reports strong sales growth of Travelan

2025-01-17T11:10:11.000Z - 1 year ago

Immuron reports strong sales growth of Travelan

Immuron Travelan® continued strong sales growth

Fri, 17 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Travelan® continued strong sales growth

Immuron announces research collaboration agreement with Monash University

2025-01-15T11:05:46.000Z - 1 year ago

Immuron announces research collaboration agreement with Monash University

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Wed, 15 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Immuron announces Travelan clinical trial update

2025-01-14T11:10:34.000Z - 1 year ago

Immuron announces Travelan clinical trial update

Immuron Announces Travelan® Clinical Trial Update

Tue, 14 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Announces Travelan® Clinical Trial Update

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Mon, 02 Dec 2024 06:00:00 -0500 - 1 year ago

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Thu, 21 Nov 2024 18:33:00 -0500 - 1 year ago

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Mon, 18 Nov 2024 08:30:00 -0500 - 1 year ago

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

Wed, 16 Oct 2024 06:00:00 -0400 - 1 year ago

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

Immuron reports Q3 sales of Travelan up 13% vs. Q2

2024-10-15T10:10:20.000Z - 1 year ago

Immuron reports Q3 sales of Travelan up 13% vs. Q2

Immuron Travelan® continued strong sales growth

Tue, 15 Oct 2024 06:00:00 -0400 - 1 year ago

Immuron Travelan® continued strong sales growth

Immuron says NMRC completes interim analysis for evaluation in Campylobacter

2024-10-05T09:06:00.000Z - 1 year ago

Immuron says NMRC completes interim analysis for evaluation in Campylobacter

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Fri, 04 Oct 2024 06:30:00 -0400 - 1 year ago

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Immuron trading halted, news pending

2024-10-02T23:10:07.000Z - 1 year ago

Immuron trading halted, news pending

Immuron initiated with a Buy at Litchfield Hills

2024-09-26T13:25:16.000Z - 2 years ago

Immuron initiated with a Buy at Litchfield Hills

Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma

Sep 19, 2024, 9:42 AM EDT - 2 years ago

Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma

Immuron plans Phase 2 trial for IMM-529 following FDA review

2024-09-05T16:00:45.000Z - 2 years ago

Immuron plans Phase 2 trial for IMM-529 following FDA review

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Sep 5, 2024, 11:54 AM EDT - 2 years ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 2 years ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS GOVX

Immuron announces new DoD research award for NMRC

2024-08-16T10:02:59.000Z - 2 years ago

Immuron announces new DoD research award for NMRC

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Aug 16, 2024, 6:00 AM EDT - 2 years ago

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Aug 15, 2024, 6:14 PM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Aug 7, 2024, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Immuron announces record Travelen sales globally

2024-07-15T12:10:03.000Z - 2 years ago

Immuron announces record Travelen sales globally

Immuron requests pre-IND meeting for IMM-529 with FDA filing

Jul 2, 2024, 6:00 AM EDT - 2 years ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing

Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 2 years ago

Immuron Board Changes

Immuron CEO Steven Lydeamore to present at Peak Sky High

May 31, 2024, 6:00 AM EDT - 2 years ago

Immuron CEO Steven Lydeamore to present at Peak Sky High

Immuron Limited to Present at the Emerging Growth Conference

May 7, 2024, 6:00 AM EDT - 2 years ago

Immuron Limited to Present at the Emerging Growth Conference

Immuron Director Resignation

May 3, 2024, 6:00 AM EDT - 2 years ago

Immuron Director Resignation

Immuron to host Live Virtual Event

Apr 15, 2024, 6:00 AM EDT - 2 years ago

Immuron to host Live Virtual Event

Immuron Travelan® sales continued strong growth

Apr 10, 2024, 6:00 AM EDT - 2 years ago

Immuron Travelan® sales continued strong growth

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Mar 7, 2024, 6:00 AM EST - 2 years ago

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Immuron Presentation Australian Biologics Festival 2024

Feb 21, 2024, 6:00 AM EST - 2 years ago

Immuron Presentation Australian Biologics Festival 2024

Immuron achieves record Travelan® sales

Feb 13, 2024, 6:00 AM EST - 2 years ago

Immuron achieves record Travelan® sales

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Feb 8, 2024, 6:00 AM EST - 2 years ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Immuron achieves record half yearly Travelan® sales

Jan 16, 2024, 6:00 AM EST - 2 years ago

Immuron achieves record half yearly Travelan® sales

Immuron Clinical Trials Update

Dec 22, 2023, 6:00 AM EST - 2 years ago

Immuron Clinical Trials Update

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

Dec 4, 2023, 6:00 AM EST - 2 years ago

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Nov 13, 2023, 6:00 PM EST - 2 years ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 30, 2023, 7:21 AM EDT - 2 years ago

Immuron CEO Steven Lydeamore presented at AusBioInvest

Immuron Announces Travelan® Clinical Study Cohort 2 commences

Oct 18, 2023, 6:00 AM EDT - 3 years ago

Immuron Announces Travelan® Clinical Study Cohort 2 commences

Immuron achieves record quarterly Travelan® sales

Oct 11, 2023, 6:00 AM EDT - 3 years ago

Immuron achieves record quarterly Travelan® sales

Immuron Limited Announces Participation in the LD Micro Main Event XVI

Sep 18, 2023, 7:30 AM EDT - 3 years ago

Immuron Limited Announces Participation in the LD Micro Main Event XVI

ScanStock
ScanStock Jul. 28 at 10:17 PM
Big bulls calling you APUS right now for a run! Looks like they might be right, Loads of bulls moving to APUS now! The next low float stock to squeeze north Look APUS starting to run with fresh news <-- $BDRX $BJDX $IMRN $VKTX long it
0 · Reply
Baseball89
Baseball89 Jul. 27 at 11:21 PM
$IMRN
0 · Reply
prismmarketview
prismmarketview Jul. 16 at 8:45 PM
$IMRN Immuron Ltd. reported unaudited global Travelan sales reached AUD$7.7 million for the full fiscal year 2026, marking a 6% increase over the prior year and delivering four consecutive quarters of year-over-year revenue growth. https://prismmarketview.com/companies/immuron-limited/#news
0 · Reply
STACKD0E
STACKD0E Jul. 16 at 10:57 AM
$BRIA $IMRN $EVTL $AIRO $TMQ ✨️
0 · Reply
jamsolotradez
jamsolotradez Jul. 10 at 1:42 PM
$IMRN wheres the volume at?
0 · Reply
jamsolotradez
jamsolotradez Jul. 10 at 1:41 PM
$IMRN let this week be the week 🤣
0 · Reply
jamsolotradez
jamsolotradez Jul. 10 at 1:41 PM
$IMRN
0 · Reply
Tryitin
Tryitin Jul. 9 at 10:33 PM
$IMRN Holding gains for the third day and chart is prepping for a spike up IMO. Just a matter of time but imminent!
0 · Reply
Victorious123
Victorious123 Jul. 9 at 7:34 PM
$IMRN
0 · Reply
jamsolotradez
jamsolotradez Jul. 9 at 8:45 AM
$IMRN on my way back from the school run and were still grinding up, lets see what today holds $2+ is easy if we brake through $1.60
0 · Reply
TheLocoPro
TheLocoPro Jul. 8 at 7:45 PM
$IMRN more government contracts coming any time
0 · Reply
StockfatherOG
StockfatherOG Jul. 8 at 7:44 PM
$IMRN weak hands will get shaken out before the real move. I’ll keep accumulating.
0 · Reply
t_baggin_u
t_baggin_u Jul. 8 at 7:43 PM
$IMRN yeah, pump pump pump let’s go, I want to get out 🍀
0 · Reply
UnforgivingTrader
UnforgivingTrader Jul. 8 at 7:34 PM
$IMRN best biotech gem to load up before catalysts hit. No dilution or debt..don’t see this too often. $EDBL $BIYA $YAAS could bounce here
0 · Reply
UnforgivingTrader
UnforgivingTrader Jul. 8 at 7:33 PM
$IMRN added more here
0 · Reply
Deblitorator
Deblitorator Jul. 8 at 7:32 PM
$IMRN about to sky rocket to $5 in the coming weeks.. $VTAK $SRXH $NVVE $TVRD potential ah movers.
0 · Reply
Tryitin
Tryitin Jul. 8 at 7:14 PM
$IMRN Holding gains steadily from yesterday and gradually pushing higher. Could this be an after hour runner without news like last time? Lets Go!
0 · Reply
TheLocoPro
TheLocoPro Jul. 8 at 1:32 PM
$IMRN clear room to $1.60 then we break that it will see 2+
0 · Reply
UnforgivingTrader
UnforgivingTrader Jul. 8 at 1:31 PM
$IMRN will be the biggest biotech run of the year in my opinion…the chairman of the board was the CEO of PolyNovo taking it from a $30M MC to $2B+ Imagine how high he takes Immuron 💥 $VTAK $EDBL $ONFO $BATL making moves at open. Volume will soon rotate into $IMRN
0 · Reply
Adrennaline
Adrennaline Jul. 8 at 1:28 PM
$IMRN looks very good
0 · Reply
Adrennaline
Adrennaline Jul. 8 at 1:28 PM
$IMRN
0 · Reply
StockfatherOG
StockfatherOG Jul. 8 at 1:27 PM
$IMRN nice buys on the tape flowing in. The start of a multi week run.
0 · Reply